NeuroMetrix IPO To Help Build Direct Sales Of Neuropathy Diagnostic
This article was originally published in The Gray Sheet
Executive Summary
NeuroMetrix will attempt to increase primary care physician adoption of its NC-stat neuropathy diagnostic system with the proceeds of an initial public offering of up to $34.5 mil. in stock